In February 2024, the FDA approved lifileucel (LN-44), a tumor infiltrating lymphocyte (TIL) therapy for advanced melanoma. This is the first of its kind for solid tumors and represents a significant step forward for melanoma treatment. TIL therapy harnesses a patient's own immune system to fight cancer. Doctors extract immune cells from a patient's tumor, grow them in a lab, and then reinfuse them back into the patient. These TILs are specifically targeted to fight the patient's unique cancer cells. This therapy is particularly promising for patients whose melanoma has not responded to other treatments like checkpoint inhibitors or targeted therapy. Studies have shown a 32% response rate among patients who received TIL therapy, and over half of those who responded maintained that response for more than 3 years. Jose Lutzky, MD, a skin cancer physician at Sylvester Comprehensive Cancer Center, emphasized the significance of TIL therapy as it offers a new option for patients with limited treatment choices and builds upon the success of previous immunotherapies in melanoma. Sylvester is also participating in a clinical trial to further improve TIL therapy by genetically modifying the immune cells to enhance their effectiveness. While TIL therapy offers great promise, it is not without challenges. The treatment process can be demanding, involving surgery, chemotherapy, and post infusion treatments. However, the potential benefits outweigh the difficulties for many patients. The approval of TIL therapy marks a new era in melanoma treatment, offering hope for patients with advanced disease. In an interview with Targeted Oncology, Lutzky, director of cutaneous oncology, medical director of the Clinical Trials Coordination Unit, and cutaneous and ocular oncology site disease group lead, discussed TIL therapy in melanoma and a study (NCT05361174) taking place at Sylvester Comprehensive Cancer Center looking at a modified TIL option. Click the link in our bio for more. #TILtherapy #MelanomaTreatment #AdvancedMelanoma #CellTherapy #Immunotherapy #cancerresearch #SkinCancerAwarenessMonth
It is officially May 1, 2024, also known as #MelanomaAwarenessMonth. I wrote the Governor of Texas @govabbott last year, and he replied with the following. IN THE NAME AND IN THE AUTHORITY OF THE STATE OF TEXAS GOVERNOR To all to whom these presents shall come, Greetings: Know ye that this official recognition is presented to all observing Melanoma Awareness Month May 2023 Texas is known the world over as a hub of science and medicine. Home to cutting-edge technologies, prestigious research institutions, and unrivaled health care facilities, the Lone Star State continues to lead the way in the diagnosis and treatment of many ifferent types of cancers. While cancer of any form can be a difficult and scary diagnosis for both patients and their families, melanoma can impact all Texans and Americans, regardless of race, ethnicity, or gender. Melanoma is a skin cancer most often caused by ultraviolet rays, and those with weakened immune systems or a family history of melanoma face a heightened risk. This type of cancer can be prevented by using sunscreen, wearing protective eyewear and clothing, and limiting sun exposure. Early detection and prevention measures are critical to defeating this cancer, and many patients have found effective treatments that win the battle. In Texas, we know that it is not our challenges that define us, but rather how we rise above them. By raising awareness of melanoma and its precursors, supporting affected patients, and advocating for vital research, we can glimpse a better and brighter tomorrow. I applaud the many organizations that lend a helping hand to patients and families affected by melanoma, and I look forward to the day when this cruef disease is relegated to the past. First Lady Cecilia Abbott joins me in encouraging aff Texans to learn more about melanoma and its prevention. In testimony whereof, I have signed my name and caused the Seal of the State of Texas to be affixed at the City of Austin this the 1st day of May, 2023. Greg Abbott Governor of Texas #MucosalMelanoma #Melanoma #MucosalMelanomaSurvivor #EndCancer #CellTherapy #AdvancedCellTherapies #TIL #TILtherapy #yourTILspeaker
In the summer of July 2022, I left my previous career and took some time off. I cashed in my 401(k) and lived off my credit cards and I didn’t know how but I knew I wanted to be an inspirational speaker. When there is no blueprint, you gotta create one. I believe everything happens for a reason and facing my mortality is the best thing that ever happened to me. It forced me to see whats truly important, time. You cant rewind it and you cant get it back. I used to pride myself on my 800+ credit score, everything I did was based around finances. I was always chasing the idea that once I was debt-free and had $ in the bank that I could move forward in life. I was wrong. My current credit score is horrible, in fact, I don’t even have any credit anymore or even two nickels to rub together. I believed in myself, and so I invested in myself, and because of that, I’ve been able to share my story and help others globally which is priceless. There is the saying that if you can’t help yourself, you can’t help others which is another reason why I wrote and self published this book. I also have to generate an income. The long-term financial toxicity of a cancer survivor is a whole other post but there’s no financial discounts or rewards for being in a clinical trial or surviving cancer. You still have the same finances as the rest of the population always has but now you also have the additional cost that adds up when you hit your out-of-pocket deductible for your insurance every year. I would appreciate any and all support by simply just sharing this post, commenting, and liking it, as well as purchasing my book if your able. I’ve provided the link below in my bio I love y’all. #MucosalMelanomaSurvivor #yourTILspeaker #Believe #Advocate #CancerSurvivor #MucosalMelanoma #EndCancer #CellTherapy #TIL #TILtherapy
Check out this must-read article exploring the latest advancements in melanoma treatment! Whether you're a seasoned pro or a budding enthusiast, there's something for everyone in this insightful piece. Explore the innovative developments in TIL therapy for metastatic melanoma, providing patients who have failed to respond to prior treatments with newfound hope. 👉Link in Bio: Category: Medical Discoveries Follow us for Daily Stories in the Medical Space #TILTherapy #CancerTreatment #FDAApproval #MetastaticMelanoma #Oncology #HealthcareAdvancements #HealthTech #HealthcareAdvancements #PatientCare #Immunotherapy
I did it! I can now add Self-Published Author to my resume. I don’t care what the odds are, in anything, I’ll defy them. Watch me! #MucosalMelanomaSurvivor #MucosalMelanoma #Melanoma #yourTILspeaker #TilTherapy #TILs #RAREcancer #RAREdisease #CancerSurvivor #EndCancer #CellTherapy #Advocate #Author #SelfPublished
The recent approval of the cellular therapy lifileucel (LN-44; Amtagvi) marks a significant advance in the treatment of patients with melanoma, especially those with advanced stages of the disease, as it offers a novel personalized approach. Click the link in our bio to read more on this special report and gain insights from Howard D. Edington, MD of @ahntoday and Omid Hamid, MD of The Angeles Clinic and Research Institute in Los Angeles, California. #MelanomaHope #AdvancedMelanomaTreatment #DurableEfficacy #Melsm #melanoma #NovelCancerTherapy #CancerTreatmentBreakthrough #Lifileucel #LN44 #Amtagvi #TILTherapy #CARTCelltherapy #CART
Breakthrough Alert: FDA Approves Revolutionary TIL Therapy for Solid Tumors 🌟 1️⃣ Innovative Milestone: Iovance Biotherapeutics’ lifileucel, now known as Amtagvi, becomes the first one-time cell therapy approved for a solid tumor, specifically advanced melanoma. 2️⃣ FDA’s Accelerated Approval: Fast-tracked approval of Amtagvi highlights its potential to bring clinical benefit to patients with serious diseases. 3️⃣ Hope for Advanced Melanoma Patients: Amtagvi offers new treatment options for those who have exhausted standard therapies, with 8,000 people in the U.S. losing their battle to melanoma annually. 4️⃣ Decades of Research Pay Off: TIL technology, developed in 1982, has matured over nearly 40 years, showcasing exceptional efficacy in treating advanced melanoma. 5️⃣ Promising Future: Beyond melanoma, the potential of TIL therapy extends to other solid tumor types, promising a new era in cancer treatment. 🔬 This marks a new chapter in immunotherapy, with Amtagvi leading the charge. Let’s celebrate this scientific breakthrough and the hope it brings to countless lives. 💖 #TILTherapy #CancerBreakthrough #Immunotherapy #FightMelanoma #FDAApproval #innovativetreatments #mdacc #cancersurvivors Source: https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-amtagvi-til-therapy-melanoma#:~:text=FDA%20has%20approved%20the%20first,%2Dinfiltrating%20lymphocytes%2C%20or%20TILs.
Still my favorite Certificate, and most proud accomplishment. By the time I did #TILtherapy, this treatment wasn’t really a choice but my only choice b/c of a lack of options. Now #TIL is FDA approved as a 2nd option for unrespectable metastatic melanoma. Speaking about TIL and my experience is who I am and what I do. This certificate is both my credentials and my disclosures. Cheers! #MucosalMelanomaSurvivor #MucosalMelanoma #Melanoma #EndCancer #SolidTumors #CellTherapy #yourTILspeaker #ClinicalTrials #C484
Throwback to when @nbcnews visited Moffitt to discuss the FDA approval of TIL therapy with Dr. Patrick Hwu. This first-of-its-kind cellular immunotherapy was pioneered at Moffitt and is now available for patients with advanced melanoma. ➡️ Watch the full story [link in bio] #TILTherapy #CancerResearch #MoffittCancerCenter #Moffitt
Day 2 of 3 in Washington D.C. with my #MelaHomies. #IYKYK but becoming a MelaHomie is not something anyone seeks out or asks for. To become a member you have to be loud, proud, and feral as F*** as a voice for something bigger than yourself, leaving all Ego at the curb. The reward is the gift of connection, compassion, and empathy b/c the lived experience 1st hand is not only what people want but what they seek. Being able to provide this patient to patient perspective is made possible b/c of the technology of what is today, the present but also the future. It’s 2024 and the internet is in everyone’s pocket and the landscape of engagement is in the hands of everyone. Life is moving forward, not backward which is why I stress the need to adapt, and overcome. You can’t change the past, but you can do your best to prepare for the future. It all boils down to being proactive instead of reactive. “Experts fail b/c they are experts in a world that no longer exists”. As the #PatientExperience holds a value that is so priceless, nothing else can or will ever compare to bonds formed when someone just gets it. With time comes change and with change is the evolution that the way things used to be, is not the way that things are and that’s okay. That’s why I always stress that It’s so critically important to become comfortable with being uncomfortable, coming outside of yourself, and knowing the worth of your story will be the source of change in someone’s. Everywhere I go and everything I do is so I can be a source for the next person, provide more than what I had when I was in that position in 2018-2019. This is not all but just some of the KOLs I’m blessed to know. I love you all and thank you for sharing your voices on a local, state, federal, and global level! Keep smashing it and Happy Hill Day! @theleahalexis @jenn_patrice @xstaticstacey @patrickguddal @thecancerfighterseanwachter @beingbrittanny @pattypoph @melan.suncare @neilcorman @my_melanoma_world @thereelstacey @curemelanoma #MucosalMelanomaSurvivor #MucosalMelanoma #EndCancer #TeleHealthSuoerBowl #TILtherapy #ShareYourStory #TheMoreYouKnow #CellTherapy #AdvancedCellTherapy
Very cool to meet Denise Hamilton yesterday at the NSA North Texas monthly meeting. Loved her perspective on “Sharing Your Message in a Noisy World” as her content for the morning was directly aligned with adapting and evolving to what is and mot resting comfortably in what was. A couple of notes I took in the morning really resonated with me. -“It’s. It bragging if your stating the facts” -“Wisdom has been replaced with Knowledge” -“What is your Promise, what value do you bring to your audience?” -“Nobody cares, place yourself in your audience position, what do they care about? Is about me or my audience?” I left just a little early from the event but I kept thinking to myself what Apollo Creed said to Rocky -“What are you waiting for, there is no tomorrow. There is no tomorrow!” #MucosalMelanomaSurvivor #MucosalMelanoma #MucosalMelanomaAwarenessMonth #TIL #TILtherapy #EndCancer #Believe #Love #NSANT
The #USFDA approves the first tumor-infiltrating lymphocyte therapy to treat #solidtumors. #Iovance is currently conducting confirmatory trials to support this accelerated FDA approval of lifileucel in TILVANCE-301. #cancerfax #TILtherapy #cancer #treatment #immunotherapy
A breakthrough therapy called tumor-infiltrating lymphocyte (TIL) has recently been approved by the FDA. This first-of-its-kind cellular immunotherapy was pioneered at Moffitt Cancer Center and is now available for patients with advanced melanoma. ➡️ Learn more about TIL and what it means for the future of treating solid tumors [link in bio] #TILTherapy #MoffittCancerCenter #Moffitt #CancerResearch
For decades, advanced Melanoma, the deadliest form of skin cancer, has cast a dark shadow, leaving patients with smaller treatment options and a grim prognosis. However, a recent breakthrough has given rise to hope with new treatment for Melanoma as the FDA approves Amtagvi, a revolutionary cellular therapy that utilizes the power of a patient's immune system to fight the aggressive disease. This personalized approach, known as tumor-infiltrating lymphocyte (TIL) therapy, represents a shift in cancer treatment, offering a lifeline to those who have exhausted conventional methods. . . . #BlessedBulletin #TIL #TILTherapy #FDA #melanoma #melanomawarrior #melanomasurvivor #melanomaawareness #melanoma #melanomacancer #melanomatreatment #melanomaprevention #cancerawareness #cancersupport #cancerprevention #cancerjourney #FDA #fda #FDAapproval #FDAregistered #science #sciencefacts #sciencenews
A first-of-its-kind cellular immunotherapy pioneered at Moffitt Cancer Center is now available for patients with advanced melanoma. The one-time T-cell therapy infusion uses a patient’s own immune cells to fight their cancer. It’s the first Food and Drug Administration approval of a cell therapy for solid tumors. ➡️ Learn more about TIL, short for tumor-infiltrating lymphocyte therapy [link in bio] #TILTherapy #MoffittCancerCenter #Moffitt #CancerResearch
I’m excited to announce the launch of my new website specific towards my Speaking Engagements yourTILspeaker.com This new site is will be geared specifically towards sharing my story and experience with #TILtherapy. MucosalMelanomaSurvivor.com focus will still be in the Advocacy space. Both sites a part of Mucosal Melanoma Survivor LLC. The video below is from one of my engagements last month with the @bcabloodcenters at their Board of Directors meeting at @delcoronado Sending #Love to everyone! Cheers!
Did you know tumor-infiltrating lymphocyte, also known as TIL, therapy uses a patient's own immune cells to recognize and fight cancer? On average, the cell manufacturing process takes between eight and 12 weeks. What happens during this time? ➡️ Let's go behind the scenes of the cellular therapy [link in bio] #CancerResearch #TILTherapy #FDAApproval #MoffittCancerCenter #Moffitt
🌟 **TIL Therapy: Revolutionizing Cancer Treatment Worldwide! 🌎** China Accelerates into the Fast Lane! 📈 The number of cell immunotherapy trials for solid tumor treatment has surged globally, with a staggering growth from 66 in 2020 to 140 in 2022, a remarkable 110% increase! Particularly, TIL therapy trials have seen a remarkable surge, now accounting for 17.1% of all solid tumor treatments, sparking a new trend in cancer therapy that's capturing the attention of researchers and companies alike. 🎯 TIL therapy boasts natural advantages in solid tumor treatment, boasting rich tumor-specific target points, robust tumor infiltration capabilities, and minimal side effects. 🔬 On February 16, 2024, the U.S. FDA officially greenlights Iovance Biotherapeutics' lifileucel therapy for unresectable or metastatic melanoma, a groundbreaking personalized T-cell therapy using TIL sourced from the patient's body. 🚀 In early 2022, China's Grit Biotechnology's GT101 injection became the first TIL product to enter clinical trials, signaling China's entry into the global TIL therapy scene. With players like Juncell Therapeutics, LANMA BIO, and BT Gillion joining the fray, Chinese TIL therapy is on the fast track to development, exploring various indications including melanoma, cervical cancer, lung cancer, and more! 💰 According to Sullivan's forecast, the global CGT market is set to skyrocket to $22 billion by 2025, with TIL therapy leading the charge. 💡 Chinese TIL therapy is paving its own path to commercialization and industrialization, offering cost-effective treatments compared to the U.S. Stay tuned for more innovations in cancer therapy from China! 🇨🇳 🌟We have access to medical resources from all cancer hospitals in China and can assist patients in receiving treatment from the best and top-tier oncologists in the CHINA. [email protected] WhatsApp+8613717959070 #TILTherapy #CancerTreatment #Innovation #MedicalBreakthroughs #ChinaHealthcare #GlobalHealthcare #CancerResearch 🚀🔬
Unlocking the Potential: Understanding TIL Therapy for Solid Tumors What is TIL therapy? According to the immune editing theory, during the process of tumor development, the body's immune cells always play a role in killing tumor cells. Different immune cells (mainly lymphocytes) are transported to the tumor site, and these lymphocytes that have infiltrated into the tumor tissue and exerted cytotoxic effects are called tumor-infiltrating lymphocytes (TILs), including T cells, B cells, NK cells, macrophages, and various mononuclear and multinuclear immune cells, which can recognize, resist, attack, and kill tumors. TIL therapy belongs to Cellular Immunotherapy, which is a method of treating using immunocytes that are activated, proliferated, or genetically engineered. The main steps include isolating specific immune-active cells (including T cells, NK cells, DC cells, and macrophages) from tumor patients, genetic modification or amplification in vitro, functional identification, and finally, returning for treatment. TIL therapy refers to isolating tumor-infiltrating lymphocytes from tumor tissue, culturing them in vitro, expanding them massively, and then reinfusing them into the body for treatment. The main routine steps of TIL therapy include: 1. Obtaining patient tumor tissue: mainly obtained through surgery or biopsy to include TIL cells. 2. Grinding tumor tissue: This step makes it easier for T lymphocytes to grow and expand from tumor tissue. 3. Adding interleukin-2 (IL-2) for cultivation: After adding a high concentration of IL-2, on the one hand, it provides survival signals for existing TIL cells, and on the other hand, stimulates larger-scale proliferation. 4. Conducting tumor-specific recognition testing: By conducting tumor-specific recognition testing on TIL cells, screening for TIL preparation processes that can more specifically kill tumors to ensure treatment effectiveness. 5. Reinfusion of expanded TIL cells for treatment: Reinfusing expanded and screened TIL cells into the patient's body to achieve the treatment goal. whatsapp: 137 1795 9070 #TILTherapy #CancerTreatment #Immunotherapy #MedicalInnovation #tils
“I thought, ‘If I can do it and it works for me, that would be great,’ ” says Roberto, an MSK patient who received tumor-infiltrating lymphocytes (TIL) therapy. “And even if it doesn’t help me, it could still help others." TIL therapy, a new immunotherapy targeting solid tumors like Roberto's, helped his immune system grow an army of T cells to fight melanoma. A little more than a year post-treatment, Roberto is stable and back to living an active life. "I’m grateful for the care that I received from everyone at MSK.” Click the link in our bio to read more about Roberto's story and learn more about TIL therapy.
I’ve rang 3 Bells throughout my #Cancer Journey. The first was at @mdandersoncancercenter in Houston TX after I completed my radiation treatments targeted at my primary source of cancer in October of 2018. The 2nd was at @cuanschutz in Aurora CO after I completed my #TILtherapy treatment and was released from the hospital on January 20, 2020. And the 3rd was at @texas.oncology.foundation in Plano TX in January 2021 when I was going over a second PET scan that was confirmed zero uptake and that I did have a complete metabolic response. Since today is my 4 year anniversary from this date from finishing my TIL Therapy and being released from the hospital, it gives me chills. To everyone involved from the doctors, oncologist, nurses, and especially my family, I can’t thank you enough. I love you. Also, sending a giant thank you out to #IovanceBiotherapeutics, Inc. When I was admitted to the hospital on January 8, 2020 I was wheelchaired in there and could not walk. The fact that I was able to walk out of the hospital is a miracle and means so much. Thank you to everyone in your organization and I love you all. #MucosalMelanomaSurvivor #MucosalMelanoma #Melanoma #MelanomaAwarness #EndCancer #ClinicalTrials #CellTherapy #AdvancedTherapies #SolidTumors #CancerSurvivor
Day 3 at @delcoronado for the @bcabloodcenters Board of Directors Meeting. I’m a little behind on my post but better late than never. So many great people in this organization and I’m so blessed that they invited me out to share my story as a result of there work. Such a historic and beautiful place. There’s a lot of renovation going on in the main building that will not be open until next year 2025, so I definitely need to make it back to see the rest. #DelMemories #MucosalMelanomaSurvivor #MucosalMelanoma #EndCancer #TILtherapy #CellTherapy #CellExtraction #CellExpansion #AdvancedTherapies #GiveBloodSaveLives #BloodDonations #Advocate #Volunteer #Keynote #Blessed #ShareYourStory #ClinincalTrials
Day 2 at @delcoronado for the @bcabloodcenters Board of Directors Meeting. I’m a little behind on my post but better late than never. So many great people in this organization and I’m so blessed that they invited me out to share my story as a result of there work. #DelMemories #MucosalMelanomaSurvivor #MucosalMelanoma #EndCancer #TILtherapy #CellTherapy #CellExtraction #CellExpansion #AdvancedTherapies #GiveBloodSaveLives #BloodDonations #Advocate #Volunteer #Keynote #Blessed #ShareYourStory #ClinincalTrials
Day 1 Part 2 at @delcoronado for the @bcabloodcenters Board of Directors Meeting. I’m a little behind on my post but better late than never. So many great people in this organization and I’m so blessed that they invited me out to share my story as a result of there work. #DelMemories #MucosalMelanomaSurvivor #MucosalMelanoma #EndCancer #TILtherapy #CellTherapy #CellExtraction #CellExpansion #AdvancedTherapies #GiveBloodSaveLives #BloodDonations #Advocate #Volunteer #Keynote #Blessed #ShareYourStory #ClinincalTrials
Day 1 Part 1 at @delcoronado for the @bcabloodcenters Board of Directors Meeting. I’m a little behind on my post but better late than never. So many great people in this organization and I’m so blessed that they invited me out to share my story as a result of there work. #DelMemories #MucosalMelanomaSurvivor #MucosalMelanoma #EndCancer #TILtherapy #CellTherapy #CellExtraction #CellExpansion #AdvancedTherapies #GiveBloodSaveLives #BloodDonations #Advocate #Volunteer #Keynote #Blessed #ShareYourStory #ClinincalTrials
I’m very excited to share that I have been given the privilege of being this years @aimatmelanoma Honoree for the annual 5K Fundraiser at White Rock Lake Park in Dallas, TX April, 20 2024. This year is AIMs 20th anniversary. To get involved or to donate please click on my Linktree in my bio. #StepsAgainstMelanoma #MucosalMelanomaSurvivor #MucosalMelanoma #EndCancer #CellTherapy #TIL #TILs #TILtherapy
When Dr. Kammula removed Uncle Fester in 2021, rendering me #NED, I told him, “I want to share a stage with you one day.”On Tuesday this dream came true. @upmchillmancancercenter invited us to speak at their annual leadership conference. Dr. Kammula talked about his research with #TILtherapy, and I shared my story of navigating #clinicaltrials and being a #uvealmelanoma patient getting #til at UPMC. Additional excitement in the week included: - completing my biannual #scans which remain NED (see video of me rolling out of the tiny tube) - getting interviewed by @wtaetv , a local news station, for a story that will air next week - spending an evening with my @first_descents #cancerperk @mfac13 - meeting my #OMie @shanabar1 who is in a trial at UPMC from Canada - having time to get the best gluten-free pizza in the country from @mercuriospgh in Shadyside Heading home now to celebrate Christmas with my family ♥️ #ocularmelanoma #stage4 #stage4cancer #stage4survivor #cancersurvivor
On this Day in History, December 10, reflecting on the following events. 2005-Graduated from University of Texas at Dallas with a Bachelors of Arts Historical Studies 2015-Member Services for the golf department at GlenEagles Country Club in Plano, TX 2019-(picture not shown) Received news from baseline scans for #clinicaltrial for TIL therapy that I had a 1 cm metastasis to the right occipital lobe of the brain. Told I was excluded from the clinical trial due to metastasis, and should consider calling hospice and settling my affairs. With this being a phase, 2 cohort 4 clinical trial, only way to get back in the trial and have a chance to live was to stabilize or reduce brain metastasis. 5 sessions of SRS Radiation needed but insurance approval needed 1st to have on schedule to move forward. Scans to show improvement had to be completed on or before December, 24 2019-14 days. After 6 days, Insurance approval was granted. 5 sessions completed in 4 days and scanned completed on December 24, 2019. 2021-Follow up appointment with Dr. Le at Texas Oncology. Celebrated over 1+ year of CMR (complete metabolic response) 2023-Blessed to be Alive, Healthy, and continuing to celebrate life thanks to #TILtherapy which eradicated stage 4 Terminal #MucosalMelanoma. What still hits home every time I share my story is that I believed in myself and never gave up. I had to fight for my spot on the roster and Im so glad I did because I was the very last person to be dosed in this trial. When it comes to History, i’m proud to be a part of it. Jan, 15 2020-Day 0. #MucosalMelanomaSurvivor #CellTherapy #PatientExperience #EndCancer #Advocate #Believe #TheMoreYouKnow #ShareYourStory https://ir.iovance.com/news-releases/news-release-details/iovance-biotherapeutics-completes-patient-dosing-registration/
Cooper First: Researchers at MD Anderson Cancer Center at Cooper are leading the way in new approaches to treating advanced melanoma using tumor infiltrating lymphocyte (TIL) therapy. Earlier this year, MD Anderson at Cooper became the first site in the world to offer and enroll a patient in TILVANCE-301, a new randomized Phase III clinical trial evaluating the efficacy of #TILTherapy as a first line treatment versus pembrolizumab (current standard of immunotherapy care) for advanced #melanoma. “TIL therapy is a promising, personalized approach to cancer treatment,” says Young Ki Hong, MD, MPH, surgical oncologist at MD Anderson at Cooper, and principal investigator of several TIL studies. “Our patient has had a remarkable response to this therapy. Each subsequent surveillance scan has shown a continuous reduction in the size of her tumor. We are grateful for patients who participate in clinical trials. Through their own treatment, they are helping to advance cancer care for others. As she completes her treatment, we are encouraged not only by her results, but what is means for patients in the future.” Read more at the link in our bio: https://brnw.ch/21wF9sD #CooperUniversityHealthCare #CooperFirst #ToServeToHealToEducate #EndCancer
❗️TIL-терапия в сравнении с CAR-T-терапией👇🏻 TIL-терапия и терапия CAR-T клетками являются формами так называемой терапии переноса T-клеток. Этот тип иммунотерапии, направлен на усиление собственных иммунных клеток пациента, для борьбы с раковыми клетками. ❗️Обе терапии, TIL и CAR-T, включают в себя сбор иммунных клеток пациента, но TIL выращиваются напрямую из опухоли, в то время как CAR-T клетки модифицируются из нормальных Т-клеток крови. ❗️В обоих случаях клетки выращиваются в больших количествах в лаборатории, а затем возвращаются в организм пациента через внутривенный катетер. Во время выращивания клеток в лаборатории пациент может проходить химиотерапию и/или радиотерапию. ❗️Существует два основных отличия между TIL и терапией CAR-T. Во-первых, продукт TIL поликлональный, что означает, что в продукте много разных клонов Т-клеток, которые могут атаковать широкий спектр различных опухолевых антигенов. ❗️Во-вторых, TIL не генетически модифицированы, тогда как терапия CAR-T клетками включает генетическую модификацию нормальных Т-клеток. ❗️Вопрос о том, какую терапию выбрать — TIL -терапию или CAR-T-терапию — зависит от множества факторов, включая тип рака, стадию заболевания, предыдущее лечение пациента, доступность терапии и даже финансовые ресурсы. #carttherapy #tiltherapy #лечениерака #медицинскийтуризм #лечениевгермании #тилтерапия #карттерапия
❗️Как работает TIL-терапия?👇🏻 В TIL-терапии используются неизмененные опухолевые клетки для уничтожения самой опухоли. TIL клетки выращиваются напрямую из ткани опухоли, удаляемой во время хирургического вмешательства. Затем их умножают и увеличивают в больших количествах в лаборатории с интерлейкином-2 (IL-2), белком, который стимулирует быстрый рост TIL клеток. Этот процесс обычно занимает от четырех до шести недель, что означает, что пациенты могут претендовать на TIL-терапию только в том случае, если их опухоль достаточно стабильна, чтобы выдержать этот период ожидания. После успешного выращивания до миллиардов в количестве, TIL вводятся обратно пациенту, где они активно атакуют раковые клетки, не трогая здоровые клетки. Как и в большинстве других клеточных иммунотерапий, перед введением TIL требуется одна неделя химиотерапии для создания условий работы TIL клеток. 🌟Не откладывайте - свяжитесь с нами уже сегодня, и мы организуем ваше лечение 🌟 #tiltherapy #лечениерака #медицинскийтуризм #лечениевгермании
I guess call it a #transformationtuesday Each of these pics where taken within 1 week of this exact same time each year. I exist because of one single treatment that worked when all others had failed. A literal “one and done” 1 time treatment #CellTherapy treatment called #TIL or #TILtherapy which stands for Tumor Infiltrating Lymphocytes. Everyone naturally already has these in them but when you extract them, grow them into the billions, bring your White Cell Count down to Zero, and then you get them back along with a little jump start from some IL-2 to get them moving. It’s like having an Army that is so massive that no enemy can run or hide. The enemy is Gone, like FOREVER!! The whole point of this treatment is that the TIL eats everything up. If it were to try and come back it would be eaten before it had a chance to be a micro cell. You may look a little different over time but like a fine wine, your value increases with age. Cheers! #mucosalmelanomasurvivor #mucosalmelanoma #Endcancer #clinicaltrials
So grateful to see my survival story published by such a great organization, The more I can share about #mucosalmelanoma, #celltherapy, #TILtherapy, and #clinicaltrials, the more #mucosalmelanomasurvivor will be and will eventually be able to eradicate and #EndCancer @aacr_foundation article can be found on my Linktree in my profile.
ЧТО ТАКОЕ TIL-КЛЕТОЧНАЯ ТЕРАПИЯ? ❗️TIL-терапия - это тип клеточной иммунотерапии, который используется для лечения плоскоклеточного рака головы и шеи, меланомы, рака легких, рака мочеполовой системы и растущего списка других злокачественных опухолей. ❗️Клеточная иммунотерапия использует компоненты иммунной системы пациента для поиска и атаки специфических раковых клеток. ❗️Что такое TIL (Tumor-Infiltrating Lymphocytes - лимфоциты, инфильтрирующие опухоль)? ❗️TIL - это тип лимфоцита, который образуется в костном мозге и находится в крови и лимфатической ткани. ❗️Существует два основных типа лимфоцитов: В-лимфоциты (которые производят антитела) и Т-лимфоциты (которые помогают уничтожать опухолевые клетки и контролировать иммунные реакции). ❗️TIL перемещаются из крови в опухоли, где они могут распознавать и уничтожать раковые клетки. #tiltherapy #лечениерака #медицинскийтуризм #лечениевгермании #тилтерапия
As a rare cancer survivor of #MucosalMelanoma, I do everything I can to advocate and support in every shape, form and fashion that I can. I connected with Janelle, in March of this year. She reached out to me directly, seeking advice about this extremely #rarecancer and I shared with her everything that I could, and that I know. Larry was actually accepted into the #TILtherapy program with the expanded access, compassionate use through Iovance and was set for his extraction in October but unfortunately that did not happen due to some unfortunate circumstances. Larry passed away yesterday, and when Jenelle told me, my heart dropped. I cannot begin to explain how devastating it is to lose another survivor from this already rare community. Jenelle reached out to me and asked where to donate to and I recommended the @melanoma RARE Registry and I set up this #JustGiving page for her. This registry is one-of-a-kind and collectively will pull data that will one day, find both a cause and a cure for this nasty disease. If you are able to donate, please do. Every little bit helps. #MucosalMelanomaSurvivor #EndCancer
What an incredible event at the 22 annual #MRFNYCGala23 @curemelanoma. I’m incredibly grateful to be the first person with #MucosalMelanoma to receive the Courage Award, it’s a true honor. Going through a #clinicaltrial for #TILtherapy saved my life and completely eradicated my cancer. I am more than excited to see @FDA approval and commercial launch here In the coming months. Huge shout out to @teddimellencamp and @bravoandy for sharing the stage with me and advocating for #MelanomaAwarness Cheers! Extra prayers to you Teddi in your fight and if you need anything or I can help in any way just let me know. #MelanomaResearchFoundation #Melanoma #CureMelanoma #MucosalMelanomaSurvivor #ClinicalTrial #EndCancer #TIL
Last month I got the honor of volunteering at @curemelanoma #MRFDENGala23. What an awesome experience as I was able to meet with past MRF Gala Honorees @ceortman @plczubeck. What made this moment even more special is that we are all surviviors of a rare melanoma sub-set and we also all did a #clinicaltrial for #TILtherapy. These are rare moments, and I embrace them every chance I get. I’m very excited and looking forward to coming to #NYC for the #MRFNYCGala23 on Oct 26 at @theplazahotel #MucosalMelanomaSurvivor #MucosalMelanoma #EndCancer #MelanomaAwarness
I’m so grateful for my eyesight. Life is beautiful. #MRFNYCGala23 #MelanomaResearchFoundation #Melanoma #CureMelanoma #MucosalMelanomaSurvivor #ClinicalTrial #EndCancer #TIL #TILtherapy #MucosalMelanoma #EndCancer
The past couple days have been a whirlwind. I got my last IV, and had a central line catheter put in (no more needle pokes!). Today I checked in for my inpatient stay, and currently getting lympho-depleting chemo to prep my body for my TIL infusion next Friday. This is my first overnight hospital stay and it’s been interesting today. I’m only here for tonight, and will her discharged tomorrow. So excited to finally be at this step in my treatment! Don’t forget about my GoFundMe! https://gofund.me/bbaf285d #tiltherapy #cancertreatment #mucosalmelanoma #melanomaawareness #cancerwarrior
3 weeks from Now!! Join the MRF and myself on Thursday, October 26 �for the 22nd Annual New York Gala where they will celebrate TV Personality, Wellness Coach, host of top-rated podcast “Two �Ts in a Pod” and 2023 MRF #GetNaked Spokesperson Teddi Mellencamp, �with the Courage Award in recognition �of her bravery and willingness to share �her story to help others. By attending this gala, you’re not only treating yourself to an unforgettable evening, but you’re also supporting a worthy cause. Mark your calendars, spread the word, and get ready to shine! To learn more about the event, purchase a ticket or donate , click here https://one.bidpal.net/mrfny2023/welcome Teddi Mellencamp Andy Cohen Melanoma Research Foundation #MRFNYCGala23 #MelanomaResearchFoundation #Melanoma #CureMelanoma #MucosalMelanomaSurvivor #EndCancer #ClinicalTrial #EndCancer #TIL #TILtherapy #MucosalMelanoma #healthyliving
In honor of #breastcanceawareness month and as a cancer survivor, I also support other cancers, including #breastcancer. After my #clinicaltrial for #tiltherapy, around the same time, I was discovering I had a complete metabolic response from #mucosalmelanoma and was at a dermatologist getting checked, and felt some lumps in my chest. I knew that man could get breast cancer, but I didn’t want to take the chance of not knowing so I said something and got a biopsy immediately, but for a minute there, I remembered it was all way too familiar. #EndCancer #mucosalmelanomasurvivor #shareyourstory #patientengagement #Advocate #juicepluscomplete
Three years?!?! Forever grateful to Dr. Kammula at @upmchillmancancercenter for this life saving treatment #til #tiltherapy #stage4 #uvealmelanoma #ocularmelanoma #cancer #cancersurvivor #theincredobles
Apheresis phase of TIL trial completed yesterday! I was so nervous about them putting in the catheter so I asked for sedation. I honestly never even felt different with the drugs, but the process was so quick and easy, that whatever amount of lidocaine they shot into me was enough to get me through with no issues. The procedure only took about 5 hours (I thought it would be closer to 8 hrs) and was easy peasy. The removal of the catheter wasn’t too bad but the site is very tender. Now I just have some slight restrictions for a few days and I’m good! I start my bridge therapy chemo today for 21 days to cover some of the gap since things won’t be ready until Oct/Nov. But next TIL stop is lympho depleting chemo and then onto welcoming those TILs!!! #mucosalmelanoma #mucosalmelanomaawareness #tiltherapy #tiltreatment #cancertreatment #clinicaltrials #clinicalresearch #cancerwarrior #apheresis #cancerresearch #rarecancer #rarecancerawareness
What is immunotherapy and how is it used? For more info Visit the Website https://www.drgauravdixit.com/ Call ☎️ us @ 70425 55674 Dr.GauravDixit #Immunotherapy #CancerTreatment #CAR-T #CheckPointInhibitors #TILtherapy #MonoclonalAntibodies #TherapeuticVaccines
Out of all my certificates, this one by far is my favorite. #TILtherapy saved my life and eradicated my #mucosalmelanoma I feel so blessed for #clinicaltrialsday
My most prized possession. I’m more proud of this than anything I’ve ever done. #medicine #biologics #scienceandenvironment #tumorinfiltratinglymphocytes #future #celltherapy #mentalhealth #WuTangClan #MrBeast #surfing #skateboarding #snowboarding #quicksilver #gopro #health #survivorship #healthyliving #EndCancer #cancersucks #MRFAdvocacyDays23 #OutoftheShadows #TIL #Tiltherapy #Mucosalmelanoma #advocate #mucosalmelanomasurvivor #advocacy #melanoma #raredisease #shareyourstory
Hello to Everyone, “I’m out the sunroof yelling thank God it’s Sunday, y’all let’s show a little love” Yeah, everyone that knows me knows my favorite thing to do in this world is share my story of cancer survival. When you get diagnosed with metastatic malignant Mucosal Melanoma, the only thing that shows up when you re-search it says that you have a 14% or less chance of surviving five years and once you get to stage for your odds are less than nine months. Well I’m approaching my five years since diagnosis and I still have no clue and neither did the doctors on what caused it or why none of the treatments that I tried worked until I got into a clinical trial. This RARE registry right here is going to be the tool that the doctors in researchers can used to collectively find out exactly what it is that has in common with this extremely small rare community so we can further figure out a way to fight it and treat it, and furthermore prevent it. Please take the time to click on it register and fill it out. I myself have a lot of history with the disease and thought it would take quite a while, but to be honest it’s actually very super easy. Yes, there are a few parts that do take a little bit more time than others but trust me, it is so well worth it, and we need it done. Also, please like and share. This month is actually Mucosal Melanoma Month and again, it was a clinical trial that saved my life. Also, @bobmarley passed away of Acral Mellanoma which is another very rare subtype of Melanoma like Mucosal Melanoma. If I’m not mistaken, he was 36 years old. I was 36 when I was diagnosed. @melanoma @curemelanoma @aimatmelanoma @rareadvocacy @rare_advocates @knowrare #celltherapy #medicine #medicalsciences #biologics #scienceandenvironment #health #quality #Til #EndCancer #cancersucks #OutoftheShadows #tumorinfiltratinglymphocytes #Tiltherapy #Mucosalmelanoma #mucosalmelanomasurvivor #future #mentalhealthawareness #MRFAdvocacydays23 #mentalhealth #MrBeast #mentalhealthsupport #survivorship https://www.raremelanoma.org/m-home
Hello and thank you to everyone who posted, called, or text me this past Tuesday for my birthday. I’ve been in Washington DC this past week advocating for melanoma patients for clinical trial diversity, telehealth access without restrictions from state to state, as well as a few other important initiatives on behalf of the MRF @curemelanoma I know this is one of the biggest challenges in the Melanoma community, especially rare melanomas and I couldn’t of thought of a better way to spend my birthday then to meet other survivors, thrivers, advocates, patients, doctors sponsors, and foundations that are all trying to do something about the most deadly cancer there is. It’s all about walking the walk that you talk na mean. I also got to attend a inpatient forum for the MRA @melanoma which was also an incredible event which is extremely beneficial. I heard a quote this past week that just made so much sense. “Melanoma is the cancer that gave cancer a bad name. ” Thanks again everyone for all the love and God bless #celltherapy #medicine #medicalsciences #biologics #scienceandenvironment #health #quality #Til #EndCancer #cancersucks #tumorinfiltratinglymphocytes #Tiltherapy #Mucosalmelanoma #mucosalmelanomasurvivor #future #mentalhealthawareness #mentalhealth #MRFAdvocacydays23 #mentalhealthsupport #survivorship
celltherapy #medicine #medicalsciences #biologics #scienceandenvironment #health #quality #Til #tumorinfiltratinglymphocytes #Tiltherapy #Mucosalmelanoma #mucosalmelanomasurvivor #future #mentalhealthawareness #mentalhealth #mentalhealthsupport #survivorship Being that that today is #nationalrarediseaseday I figure there is no better time in the present. Today’s been a very special day for me. The MRA released an article about my story fighting Mucosal Melanoma. https://www.curemelanoma.org/blog/article/facing-mucosal-melanoma-this-patient-turned-to-a-til-clinical-trial I am also I’m very proud to announce that I’ve been nominated to receive the courage award from the MRF at the 2023 Gala in New York City at the Plaza hotel. I will be the first person ever to receive this award for Mucosal Melanoma, and I am very honored and humbled for this. This will be on October 26, 2023 and I will post more information as it becomes available. I’ll continue to post updates and share details about my story on my personal website at https://mucosalmelanomasurvivor.com/ In conjunction with my own personal website, I am also working with a few select people on starting a 501C nonprofit so I can physically and literally help others that are fighting this disease. I want to thank everyone for their support who has helped me get to this point. Sending love to everyone and God bless. https://melanoma.org/how-to-help/volunteer/events/galas/
I’ve had people all over the world find me here to ask me questions about #tiltherapy. I finally posted two posts today on my blog www.FutureHappySelf.com. One on What to Expect with #til treatment and the other on What to Pack (also helpful for other types of #longhospitalstay). #uvealmelanoma #uvealmelanomatreatment #ocularmelanoma #ocularmelanomasurvivor #stage4cancersurvivor
Today’s question regarding cell and gene therapy: “What is TIL therapy?” TIL therapy is an emerging type of treatment that builds upon success in the fight against cancer. TIL stands for “tumor-infiltrating lymphocytes”, which are immune cells (T cells or B cells) that have successfully infiltrated tumors. Since the lymphocytes are already targeting the tumor, there are no genetic modifications needed to point them toward the tumor. The objective for scientists is to create more TILs. Doctors can remove TILs from the patient’s tumor and send them to a laboratory, where they are multiplied. The new TILs are inserted back into the patient’s body. This is the basis of TIL therapy, an exciting approach that focuses on amplifying cells making headway against cancer! #TILtherapy #tumorinfiltratinglymphocytes #TILs #celltherapy
Check out my newly published article detailing TIL therapy -- an adoptive cell therapeutic strategy that harnesses your naturally occurring anti-tumor immune cells as a personalized treatment approach. Adoptive cell therapy (ACT) is a type of immunotherapy where an individual’s immune cells are harvested and expanded to help elicit a tumor-specific, cell-mediated response against cancer cells; it includes chimeric antigen receptor (CAR) T-cell therapy (CAR-T), engineered T cell receptor (TCR)-based T cell (TCR-T) immunotherapy and tumor-infiltrating lymphocytes (TILs). https://www.targetedonc.com/view/til-therapy-as-a-personalized-treatment-strategy-for-nsclc #TILtherapy #cancer #oncology #cancerresearch #NSCLC #immunotherapy
Another day in the lab ... . . . . . Morning was spent training the production team on more aseptic techniques. Specifically bag extractions and working with syringes & needles. . Afternoon was spent checkin TIL cell populations in 6 well plates ( triplicates of different media combinations was assessed) and then imaging. Looking for stress, growth (confluence) contamination and other morphological characteristics that help us develop donor profiles. . . #tiltherapy #celltherapy #cartcell #cartcelltherapy #scientistlife #inthelab #labtime #celltherapylab #aseptic #aseptictechnique #asepticism #cellculture #cellculturelab #cellularimaging #microscopicimaging
Workin in a small lab means wearing many hats ! Today I got to work on a small project- assessing signal transduction with lentiviral vectors in relation to downstream CD19 and CD20 cell expression. . Then, I got to help a QC scientist clean their BSC with proper aseptic techniques and material transfer. . . . . . . #cartcelltherapy #cartcell #celltherapy #cancercelltherapy #tilcelltherapy #tiltherapy #cd19 #cd20 #lentiviralvector #lentivirus #personalizedmedicine #regenmed #regenerativemedicine #autologous #allogenic #lablife #qualitycontrol #biochemistry
Treatment of metastatic melanoma: immunotherapy according to the TIL protocol 🔍 Melanoma is the rarest type of skin cancer, but it is also the most dangerous one. It develops rapidly and metastasizes early. At the same time, this tumor is one of the most susceptible to immunotherapy. This type of treatment demonstrates good results even in metastatic tumors. The doctors abroad use immunotherapy according to the TIL protocol (i.e. tumour-infiltrating lymphocytes) for the treatment of melanoma at the advanced stage. TIL therapy is based on the separation and cultivation of tumor-specific lymphocytes. These are white blood cells which are responsible for immunity. During the treatment, human own lymphocytes are obtained from the tumor tissue. They are located inside the melanoma, as they migrate to the tumor to fight cancer. The next step is the activation of these cells and their cultivation in the laboratory conditions. Then the cells are injected back into the patient's body. 🔸 Why does it work? Our immunity can destroy cancer cells and does it all the time. But melanoma can defend itself against immunity. Therefore, despite the migration of lymphocytes into the tumor, they cannot destroy it. There are several reasons for this: ◾ Insufficient number of cells ◾ Their low tumor reactivity ◾ Excretion of substances by tumor, which reduce the activity of immune cells These problems are solved during the treatment according to the TIL protocol. The immune cells are extracted from the tumor and cultivated in the laboratory in order to increase their number. At the same time, their reactivity increases. The cells develop without inhibiting tumor action, so when they are injected into the body, the doctors usually obtain good response to treatment. In the most favorable cases, the tumor and its metastatic foci are completely destroyed by immune cells. 👉 Details about TIL, the results of this therapy and the treatment of melanoma abroad can be found on the Booking Health portal. ------------ #BookingHealth #BookingHealth_treatment #melanoma #metastaticmelanoma #skinmelanoma #melanomatreatment #skincancertreatment #immunotherapyforcancer #TILtherapy
・・・ How does T-cell transfer therapy work against cancer? T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able to attack cancer. T-cell transfer therapy has two main types: tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy. Both involve collecting your own immune cells, growing large numbers of these cells in the lab, and then giving the cells back to you through a needle in your vein. (T-cell transfer therapy is also called adoptive cell therapy, adoptive immunotherapy, and immune cell therapy.) The process of growing your T cells in the lab can take 2 to 8 weeks. You may have treatment with chemotherapy and, maybe, radiation therapy to get rid of other immune cells during this time. Reducing your immune cells helps the transferred T cells to be more effective. After these treatments, the T cells grown in the lab will be given back to you via a needle in your vein. #repost @nationalcancerinstitute #CancerCare #CancerTreatment #Immunotherapy #TCell #TME #CarTCellTherapy #TILTherapy #NIH #CancerResearch #AboutCancer #Melanoma #CervicalCancer #BreastCancer #BrainCancer 📷: A process diagram outlines 5 major steps required to create CAR T Cell Therapy. (1) Remove blood from patient to get T cells. (2) Make CAR T Cells in the lab. (3) Grow millions of CAR T Cells. (4) Infuse CAR T Cells into patient. (5) CAR T Cells bind to cancer cells and kills them.
T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able to attack cancer. F-cell transfer therapy has two main types tumor-infiltrating lymphocytes (or TIL) therapy and CAR I-cell therapy. Both involve collecting your own immune cells, growing large numbers of these cells in the lab, and then giving the colla back to you through a needle in your vein. (Foell transfer therapy is also called adoptive cell therapy, adoptive immunotherapy, and immune cell therapy) The process of growing your T cells in the lab can take 2 to 8 weeks You may have treatment with chemotherapy and, maybe, radiation therapy to get rid of other immune cello during this time. Reducing your immune cells helps the transferred T cells to be more effective. After these treatments, the T cells grown in the lab will be given back to you via a needle in your vein Click the link in bio to see our recently updated summary on T-cell Transfer Therapy. #CancerCareCancerTreatmentImmunotherapy #TCell #TME #CarTCellTherapy #TILTherapy #NIH #CancerResearch #AboutCancer #Melanoma #Cervicalcancer #Breastcancer #BrainConcer #who #healty #cancer #treatment A process diagram outlines 5 major steps required to create CART Cell Therapy (1) Remove blood from patient to get T cells. (2) Make CART Cells in the lab. (3) Grow millions of CAR T Cells (4) Infuse CAR T Cells into patient (5) CART Cello bind to cancer cells and kills them
How does T-cell transfer therapy work against cancer? T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able to attack cancer. T-cell transfer therapy has two main types: tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy. Both involve collecting your own immune cells, growing large numbers of these cells in the lab, and then giving the cells back to you through a needle in your vein. (T-cell transfer therapy is also called adoptive cell therapy, adoptive immunotherapy, and immune cell therapy.) The process of growing your T cells in the lab can take 2 to 8 weeks. You may have treatment with chemotherapy and, maybe, radiation therapy to get rid of other immune cells during this time. Reducing your immune cells helps the transferred T cells to be more effective. After these treatments, the T cells grown in the lab will be given back to you via a needle in your vein. Click the link in bio to see our recently updated summary on T-cell Transfer Therapy. #CancerCare #CancerTreatment #Immunotherapy #TCell #TME #CarTCellTherapy #TILTherapy #NIH #CancerResearch #AboutCancer #Melanoma #CervicalCancer #BreastCancer #BrainCancer 📷: A process diagram outlines 5 major steps required to create CAR T Cell Therapy. (1) Remove blood from patient to get T cells. (2) Make CAR T Cells in the lab. (3) Grow millions of CAR T Cells. (4) Infuse CAR T Cells into patient. (5) CAR T Cells bind to cancer cells and kills them.
Have you heard of TIL therapy? This relatively new treatment is being used to fight certain types of cancer, including stage four melanoma. TIL Therapy requires three weeks of in-hospital treatment, but the results are nothing short of amazing. According to experts, TIL might even earn FDA approval sometime in 2022. Source: https://www.clickorlando.com/getting-results/2021/11/22/cancer-specialists-in-florida-see-dramatic-results-with-new-clinical-trial/ #cancerresearch #clinicaltrials #TILtherapy #stagefourcancer #melanoma #cancertreatment #beatcancer #standuptocancer #oncologyresearch #medicalresearchers #medicalresearch #fightcancer #cancerawareness #cancerresearch #cancerwarriors #fightcancertogether #cancerresearchers #biomedicalresearch #scientificresearch #biomedicalscience #healthscience #lifesciences #biopharma #healthcareindustry #lifescience #biomedicalresearchforall #bioscience #clinicaltrial #sciencelife #oncology
🛡 Immunotherapy for metastatic melanoma according to the TIL protocol (tumor-infiltrating lymphocytes) Melanoma is one of the most aggressive malignant formations. It takes lives of young people: many patients belong to the age category of 30-40 years. Melanoma develops rapidly and metastasizes early. At the same time, this tumor is one of the most susceptible to immunotherapy. This type of treatment demonstrates good results even in metastatic tumors. The doctors abroad use immunotherapy according to the TIL protocol (i.e. tumour-infiltrating lymphocytes) for the treatment of melanoma at the advanced stage. TIL therapy is based on the separation and cultivation of tumor-specific lymphocytes. These are white blood cells which are responsible for immunity. Good treatment results can be achieved in 50% of patients. Their symptoms are less severe, most tumor foci regress, the growth rate of the tumor slows down, and the duration and quality of life increase. In 20% of patients the tumor and its metastases regress completely. Although TIL therapy does not guarantee a cure, even such results should be considered impressive. After all, do not forget which patients can be treated using immunotherapy. These are mainly people with advanced stage of the disease, who no longer receive the results from other treatment methods. That is, doctors manage to achieve excellent results even the most severe cases. All details about TIL immunotherapy are collected in a medical article on our website (there is the link to the site in the profile description, look for the Blog section in the site menu). #BookingHealth #BookingHealth_treatment #TILtherapy #melanoma #metastaticmelanoma #immunotherapy #immunotherapytreatment #cancertreatment
TIL (tumor-infiltrating lymphocytes) is when T-cells are grown from the tumor itself. Adoptive cell transfer therapy, or ACT, includes a number of different types of immunotherapy treatments. Among ACT for melanoma, TIL therapy is most common.TIL therapy is a procedure in which white blood cells that have left the bloodstream and migrated towards a tumor, TIL (tumor infiltrating lymphocytes), are enriched to help fight and reduce cancers. As part of the therapy, TIL cells are extracted from a patient’s tumor, amplified in a laboratory to increase their number, and then infused back into the patient. Our melanoma physician assistant, Melissa Wilson can help you understand what the therapy is and how it works. Visit our website and contact Melissa from our home page. #melanoma #melanomawarrior #melanomatreatment #melanomasurvivor #TILtherapy
Attending the Uveal Melanoma program retreat at MD Anderson... gotta push this field further... . . . #cancer #cancerresearch #uveal #uvealmelanoma #MDAnderson #MDAndersonCancerCenter #melanoma #cell #cells #Tcell #Tcells #TIL #tillab #tiltherapy #celltherapy #immunotherapy